| INDUSTRY NEWS | UAB Awarded Prestigious Grant to Study Brain Tumors The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and the UAB Division of Neurosurgery have been awarded a prestigious SPORE, or Specialized Program of Research Excellence, grant from the National Cancer Institute for $2.3 million over three years to conduct research and develop new therapies to treat brain tumors. [University of Alabama at Birmingham] Press Release Scripps Research Scientist Awarded $500,000 Grant from Michael J. Fox Foundation to Study Parkinson Disease The Scripps Research Institute has been awarded a $500,000 grant by the Michael J. Fox Foundation to study a pair of genetic mutations that could lead to a new and potentially vital therapeutic target for Parkinson’s disease. [The Scripps Research Institute] Press Release Van Andel Institute Appoints Dr. Patrik Brundin as Chair of the Jay Van Andel Parkinson Research Lab Van Andel Institute officials announced the appointment of Patrik Brundin, M.D., Ph.D. as the inaugural holder of the Jay Van Andel Endowed Chair in Parkinson Research. [Van Andel Institute] Press Release Newron Is Exploring All Options for Safinamide Newron Pharmaceuticals S.p.A. announced that the ongoing talks with Biotie Therapeutics Corp. on the planned acquisition of Newron by Biotie have been terminated. [Newron Pharmaceuticals S.p.A.] Press Release Celldex Therapeutics Announces Orphan Drug Designation in the European Union for Rindopepimut, a Novel EGFRvIII Vaccine for Glioblastoma Celldex Therapeutics, Inc. announced that the European Medicines Agency has granted orphan drug designation for rindopepimut for the treatment of Glioblastoma. [Celldex Therapeutics, Inc.] Press Release “Glow in the Dark Brains” Aid Tumor Surgery: Clinical Trial Hopes to Improve Techniques to Remove Brain Tumors The trial, called GALA-5, will involve over 60 patients who have been newly diagnosed with glioblastoma. [University of Cambridge] Press Release |
|
|
|